Risk factors analysis for poor prognosis after percutaneous drainage in liver abscess patients with fatty liver

Table 3 Clinical symptoms and signs in patients with liver abscess and fatty liver, n (%)

Variable	Total (n = 165)	Good prognosis (n = 121)	Poor prognosis (n = 44)	χ²/t	P value
Right-upper-quadrant pain	138 (83.6)	102 (84.3)	36 (81.8)	0.168	0.682
Nausea & vomiting	110 (66.7)	78 (64.5)	32 (72.7)	0.872	0.350
Fatigue	122 (73.9)	86 (71.1)	36 (81.8)	1.571	0.210
Chills	126 (76.4)	89 (73.6)	37 (84.1)	1.725	0.189
Loss of appetite	140 (84.8)	100 (82.6)	40 (90.9)	1.476	0.226
Abdominal distension	85 (51.5)	59 (48.8)	26 (59.1)	1.176	0.279
Jaundice	46 (27.9)	29 (24.0)	17 (38.6)	3.060	0.080
Cough & sputum	60 (36.4)	40 (33.1)	20 (45.5)	2.006	0.182
Night sweats	79 (47.3)	50 (41.3)	29 (65.9)	7.086	0.008
Weight loss	67 (40.6)	43 (35.5)	24 (54.5)	4.024	0.045
Right-shoulder/back pain	38 (23.0)	25 (20.7)	13 (29.5)	1.236	0.266

P < 0.05 was considered statistically significant. Categorical variables are presented as number (percentage) [n (%)] and compared using χ² test. Continuous variables are presented as mean ± SD and compared using independent samples t-test.